{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-22-000242","form_type":"8-K","ticker":"HLF","cik":"0001180262","company_name":"HERBALIFE LTD.","filed_at":"2022-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.599039+00:00","generated_at":"2026-06-27T05:18:32.767745+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Herbalife reports record FY2021 net sales of $5.8B, Q4 down 6.6%; FY2022 guidance below 2021 adjusted EPS","bullets":["FY2021 net sales $5.8B (+4.7% YoY); reported diluted EPS $4.13, adjusted $4.79 (records).","Q4 net sales $1.3B (-6.6% YoY); reported EPS $0.37, adjusted $0.57 vs $0.59 and $0.71 a year ago.","FY2021 net income $447.2M, adjusted EBITDA $873.5M (records).","FY2022 guidance: net sales 0-6% growth, adjusted EPS $4.25-$4.75, adjusted EBITDA $785M-$845M.","Repurchased 20.4M shares for $983M in FY2021; plans $50M/quarter repurchases."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-22-000242","json":"https://secwatch.observer/filing/0001157523-22-000242.json","markdown":"https://secwatch.observer/filing/0001157523-22-000242.md","text":"https://secwatch.observer/filing/0001157523-22-000242.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1180262/000115752322000242/0001157523-22-000242-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1180262/000115752322000242/a52583940.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T05:18:32.767745+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}